News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Sergio Cifuentes: ctDNA for predicting response and prognosis in HER2-BC in NAC
May 6, 2024, 20:08

Sergio Cifuentes: ctDNA for predicting response and prognosis in HER2-BC in NAC

Sergio Cifuentes, Cancer Research Project Manager at 

“ctDNA for predicting response and prognosis in HER2-BC in NAC.
HR+: 145 and TNBC 138
TNBC: ctDNA have correlation with RCB and DFRS
HR+: ctDNA have correlation with DRFS.”

Proceed to the article.
Source: Sergio Cifuentes/X

Breast Cancer cancer CENEIT México ctDNA HER2-negative breast cancer neoadjuvant chemotherapy OncoDaily Oncology Sergio Cifuentes
Special Coverage
Blog
Mar 31, 2025, 20:43
Akhil Santhosh: Pembrolizumab and lenvatinib show promise in mesothelioma treatment
Blog
Mar 31, 2025, 20:25
Happy National Doctors’ Day - Mount Sinai Department of Medicine
Blog
Mar 31, 2025, 20:25
A rare glimpse inside doctors’ offices - Moffitt Cancer Center
Blog
Mar 31, 2025, 20:00
2 open positions in the IASLC team
Blog
Mar 31, 2025, 19:08
Predicting response to neoadjuvant chemotherapy in MIBC via interpretable multimodal deep learning
Blog
Mar 31, 2025, 19:01
Colorectal cancer affects all ages: learn your risks - Digestive Cancers Europe
Blog
Mar 31, 2025, 18:51
Insights from GUtrends25 on Urothelial Cancer Treatment by Tom Powles
Blog
Mar 31, 2025, 18:40
Celebrating National Doctors Day - Dolphins Cancer Challenge
Blog
Mar 31, 2025, 18:40
Serre-Beinier Veronique: Key Insights from ELCC 2025
Blog
Mar 31, 2025, 18:35
Binay Shah: Excited to break down barriers and bring quality care to those who need it most
Blog
Mar 31, 2025, 18:27
Bernard A. Fox: UbiVac Seeks Support and Partners to Bring DPV-001 Immunotherapy to Pediatric Cancer Trials
Career
Mar 31, 2025, 18:22
Maryam Yazdy has been appointed as the Senior Medical Director of Clinical Development at BeiGene